v3.26.1
Stock Options (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Jul. 01, 2025
Jul. 01, 2024
Apr. 01, 2024
May 17, 2024
Jul. 21, 2023
Dec. 31, 2025
Dec. 31, 2024
Noncash stock base compensation expense         $ 684,900    
Stock options granted 10,000         628,960  
Stock-Based Compensation     $ 948,200     $ 520,700 $ 1,165,400
Exercise price     $ 2.50     $ 2.50  
Stock compensation expense           $ 613,400  
Weighted-average period over which the nonvested awards expected to be recognized           2 years 14 days 1 year 6 months 18 days
Mr. Blechman [Member]              
Stock options granted       25,000      
Exercise price     $ 1.75        
Stock compensation expense       $ 34,500      
Christopher Cox, John Nicols, and Jurgen Schumacher [Member]              
Stock options granted   10,000          
Exercise price   $ 1.29          
Stock compensation expense   $ 10,400          
Contractual term of the stock options   10 years          
Stock option vested   100.00%          
Michael Blechman, Christopher Cox, and John Nicols, [Member]              
Stock options granted   5,000          
Exercise price   $ 1.29          
Stock compensation expense $ 6,500 $ 5,200          
Contractual term of the stock options   10 years          
Stock option vested   100.00%          
Christopher Cox, and John Nicols, [Member]              
Stock options granted 15,000            
Exercise price $ 0.65            
Stock compensation expense $ 9,750            
Contractual term of the stock options 10 years            
Stock option vested 100.00%            
2022 Plan              
Common stock, par value           $ 0.05  
Options to purchase           1,750,000  
Options previously granted           53,151